NASDAQ:JSPR | Profit Breakdown | Jasper Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$9.21M-$2.76M
2026-03-31-$10.95M-$1.17M
2025-12-31-$15.84M-$9.1M
2025-09-30-$19.17M-$18.74M
2025-06-30-$27.08M-$26.72M
2025-03-31-$21.8M-$21.24M
2024-12-31-$25.29M-$24.32M
2024-09-30-$19.89M-$18.64M
2024-06-30-$15.99M-$14.58M
2024-03-31-$15.07M-$13.73M
2023-12-31-$17.73M-$16.58M
2023-09-30-$19.36M-$17.54M
2023-06-30-$17.83M-$16.08M
2023-03-31-$13.95M-$14.26M
2022-12-31-$13.75M-$13.21M
2022-09-30-$12.71M-$11.86M
2022-06-30-$11.96M-$10.4M
2022-03-31-$12.78M-$2.21M
2021-12-31-$12.08M-$9.06M
2021-09-30-$10.08M-$3.41M
2021-06-30-$8.42M-$3.57M-$8.41M
2021-03-31-$6.25M$5.5M-$9.75M
2020-12-31-$5.96M-$181,637.00-$53.35M
2020-09-30-$6.01M-$209,406.00-$201,191.00
2020-06-30-$327,561.00-$3.43M-$3.43M
2020-03-31-$228,666.00$1.49M$1.43M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$83.88M-$75.8M
2024-12-31-$76.24M-$71.27M
2023-12-31-$68.86M-$64.47M
2022-12-31-$51.2M-$37.69M
2021-12-31-$36.83M-$30.64M
2020-12-31-$20.68M-$552,250.00-$31.67M